Featured Products

My Quote Request

No products added yet

6505-01-456-2066

20 Products

NDC00395-1237-91

IPECAC SYRUP,USP

NSN, MFG P/N

6505014562066

NSN

6505-01-456-2066

View More Info

NDC00395-1237-91

IPECAC SYRUP,USP

NSN, MFG P/N

6505014562066

NSN

6505-01-456-2066

MFG

HUMCO INC

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: IPECAC SYRUP USP 7% 30ML BT 12S
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 7%, 30 ML BOTTLES; 12 PER PACKAGE

NDC00069-3120-19

AZITHROMYCIN FOR ORAL SUSPENSION,USP

NSN, MFG P/N

6505014554559

NSN

6505-01-455-4559

View More Info

NDC00069-3120-19

AZITHROMYCIN FOR ORAL SUSPENSION,USP

NSN, MFG P/N

6505014554559

NSN

6505-01-455-4559

MFG

PFIZER LABORATORIES DIV OF PFIZER INC

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: AZITHROMYCIN FOR ORAL SUSPENSION 200MG/5ML 15ML BT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 200.000 MICROGRAMS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 200 MG/5 ML; 15 ML; POWDER; BOTTLE

ZITHROMAX

AZITHROMYCIN FOR ORAL SUSPENSION,USP

NSN, MFG P/N

6505014554559

NSN

6505-01-455-4559

View More Info

ZITHROMAX

AZITHROMYCIN FOR ORAL SUSPENSION,USP

NSN, MFG P/N

6505014554559

NSN

6505-01-455-4559

MFG

PFIZER LABORATORIES DIV OF PFIZER INC

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: AZITHROMYCIN FOR ORAL SUSPENSION 200MG/5ML 15ML BT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 200.000 MICROGRAMS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 200 MG/5 ML; 15 ML; POWDER; BOTTLE

0338-0550-02

HEPARIN SODIUM IN DEXTROSE INJECTION

NSN, MFG P/N

6505014555193

NSN

6505-01-455-5193

View More Info

0338-0550-02

HEPARIN SODIUM IN DEXTROSE INJECTION

NSN, MFG P/N

6505014555193

NSN

6505-01-455-5193

MFG

BAXTER GOVERNMENT CUSTOMER SERVICE

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25000.000 USP UNITS HEPARIN SODIUM ACTIVE INGREDIENT AND 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: VIAFLEX CONTAINER; 24 UNITS PER CASE

2B0802

HEPARIN SODIUM IN DEXTROSE INJECTION

NSN, MFG P/N

6505014555193

NSN

6505-01-455-5193

View More Info

2B0802

HEPARIN SODIUM IN DEXTROSE INJECTION

NSN, MFG P/N

6505014555193

NSN

6505-01-455-5193

MFG

BAXTER GOVERNMENT CUSTOMER SERVICE

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25000.000 USP UNITS HEPARIN SODIUM ACTIVE INGREDIENT AND 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: VIAFLEX CONTAINER; 24 UNITS PER CASE

NDC0338-0550-02

HEPARIN SODIUM IN DEXTROSE INJECTION

NSN, MFG P/N

6505014555193

NSN

6505-01-455-5193

View More Info

NDC0338-0550-02

HEPARIN SODIUM IN DEXTROSE INJECTION

NSN, MFG P/N

6505014555193

NSN

6505-01-455-5193

MFG

BAXTER GOVERNMENT CUSTOMER SERVICE

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25000.000 USP UNITS HEPARIN SODIUM ACTIVE INGREDIENT AND 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: VIAFLEX CONTAINER; 24 UNITS PER CASE

0338-0705-41

POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE,USP

NSN, MFG P/N

6505014555258

NSN

6505-01-455-5258

View More Info

0338-0705-41

POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE,USP

NSN, MFG P/N

6505014555258

NSN

6505-01-455-5258

MFG

BAXTER GOVERNMENT CUSTOMER SERVICE

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIEQUIVALENTS POTASSIUM CHLORIDE PER LITER
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: HIGHLY CONCENTRATED POTASSIUM CHLORIDE IN WATER FOR INJECTION; VIAFLEX CONTAINER; 24 UNITS PER CASE

2B0821

POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE,USP

NSN, MFG P/N

6505014555258

NSN

6505-01-455-5258

View More Info

2B0821

POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE,USP

NSN, MFG P/N

6505014555258

NSN

6505-01-455-5258

MFG

BAXTER GOVERNMENT CUSTOMER SERVICE

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIEQUIVALENTS POTASSIUM CHLORIDE PER LITER
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: HIGHLY CONCENTRATED POTASSIUM CHLORIDE IN WATER FOR INJECTION; VIAFLEX CONTAINER; 24 UNITS PER CASE

NDC0338-0705-41

POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE,USP

NSN, MFG P/N

6505014555258

NSN

6505-01-455-5258

View More Info

NDC0338-0705-41

POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE,USP

NSN, MFG P/N

6505014555258

NSN

6505-01-455-5258

MFG

BAXTER GOVERNMENT CUSTOMER SERVICE

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIEQUIVALENTS POTASSIUM CHLORIDE PER LITER
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: HIGHLY CONCENTRATED POTASSIUM CHLORIDE IN WATER FOR INJECTION; VIAFLEX CONTAINER; 24 UNITS PER CASE

8516000

ANTICOAGULANT CITRATE DEXTROSE SOLUTION,USP

NSN, MFG P/N

6505014555535

NSN

6505-01-455-5535

View More Info

8516000

ANTICOAGULANT CITRATE DEXTROSE SOLUTION,USP

NSN, MFG P/N

6505014555535

NSN

6505-01-455-5535

MFG

C. R. BARD INC.

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP SOLUTION A 40ML 20S
PRIMARY CONTAINER CONTENT QUANTITY: 40.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: SOLUTION A; 40 ML; 20'S; FOR USE W/ORTHOPEDIC AUTOTRANSFUSION SYSTEM

98-0223

ANTICOAGULANT CITRATE DEXTROSE SOLUTION,USP

NSN, MFG P/N

6505014555535

NSN

6505-01-455-5535

View More Info

98-0223

ANTICOAGULANT CITRATE DEXTROSE SOLUTION,USP

NSN, MFG P/N

6505014555535

NSN

6505-01-455-5535

MFG

DEFENSE MEDICAL STANDARDIZATION BOARD

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP SOLUTION A 40ML 20S
PRIMARY CONTAINER CONTENT QUANTITY: 40.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: SOLUTION A; 40 ML; 20'S; FOR USE W/ORTHOPEDIC AUTOTRANSFUSION SYSTEM

NDC00536-7620-94

SALICYLIC ACID COLLODION,MODIFIED

NSN, MFG P/N

6505014555537

NSN

6505-01-455-5537

View More Info

NDC00536-7620-94

SALICYLIC ACID COLLODION,MODIFIED

NSN, MFG P/N

6505014555537

NSN

6505-01-455-5537

MFG

WATSON PHARMA INC

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: SALICYLIC ACID COLLODION MODIFIED 13-15ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 13.000 MILLILITERS OR 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 17% IN A FLEXIBLE COLLODION OR COLLODION-LIKE VEHICLE; 13-15 ML; BOTTLE

98-0382

LUBRICANT,SURGICAL

NSN, MFG P/N

6505014557944

NSN

6505-01-455-7944

View More Info

98-0382

LUBRICANT,SURGICAL

NSN, MFG P/N

6505014557944

NSN

6505-01-455-7944

MFG

DEFENSE MEDICAL STANDARDIZATION BOARD

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: LUBRICANT SURGICAL 4OZ BT 12S
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE, PLASTIC SQUEEZE
SPECIAL FEATURES: 4 OZ; 12'S

NDC00168-0205-36

LUBRICANT,SURGICAL

NSN, MFG P/N

6505014557944

NSN

6505-01-455-7944

View More Info

NDC00168-0205-36

LUBRICANT,SURGICAL

NSN, MFG P/N

6505014557944

NSN

6505-01-455-7944

MFG

NYCOMED US INC. DIV FOUGERA/SAVAGE LABS/PHARMADERM USE CAGE CODE 60910 FOR CATALOGING.

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: LUBRICANT SURGICAL 4OZ BT 12S
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE, PLASTIC SQUEEZE
SPECIAL FEATURES: 4 OZ; 12'S

SURGILUBE

LUBRICANT,SURGICAL

NSN, MFG P/N

6505014557944

NSN

6505-01-455-7944

View More Info

SURGILUBE

LUBRICANT,SURGICAL

NSN, MFG P/N

6505014557944

NSN

6505-01-455-7944

MFG

NYCOMED US INC. DIV FOUGERA/SAVAGE LABS/PHARMADERM USE CAGE CODE 60910 FOR CATALOGING.

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: LUBRICANT SURGICAL 4OZ BT 12S
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE, PLASTIC SQUEEZE
SPECIAL FEATURES: 4 OZ; 12'S

98-0381

VERAPAMIL HYDROCHLORIDE INJECTION,USP

NSN, MFG P/N

6505014558428

NSN

6505-01-455-8428

View More Info

98-0381

VERAPAMIL HYDROCHLORIDE INJECTION,USP

NSN, MFG P/N

6505014558428

NSN

6505-01-455-8428

MFG

DEFENSE MEDICAL STANDARDIZATION BOARD

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: VERAPAMIL HYDROCHLORIDE INJECTION USP 2.5MG/ML 2ML VIAL 5S
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL OR VIAL
SPECIAL FEATURES: 2.5 MG/ML; 2 ML; AMPULE OR VIAL; 5'S

NDC00409-4011-01

VERAPAMIL HYDROCHLORIDE INJECTION,USP

NSN, MFG P/N

6505014558428

NSN

6505-01-455-8428

View More Info

NDC00409-4011-01

VERAPAMIL HYDROCHLORIDE INJECTION,USP

NSN, MFG P/N

6505014558428

NSN

6505-01-455-8428

MFG

CARDINAL HEALTH INC. DBA CARDINAL HEALTH

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: VERAPAMIL HYDROCHLORIDE INJECTION USP 2.5MG/ML 2ML VIAL 5S
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL OR VIAL
SPECIAL FEATURES: 2.5 MG/ML; 2 ML; AMPULE OR VIAL; 5'S

NDC00004-1964-02

CEFTRIAXONE SODIUM,USP

NSN, MFG P/N

6505014559983

NSN

6505-01-455-9983

View More Info

NDC00004-1964-02

CEFTRIAXONE SODIUM,USP

NSN, MFG P/N

6505014559983

NSN

6505-01-455-9983

MFG

ROCHE LABORATORIES INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CEFTRIAXONE EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTRIAXONE SODIUM STERILE USP POWDER FORM 1GM P-B BT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: PIGGYBACK

ROCEPHIN

CEFTRIAXONE SODIUM,USP

NSN, MFG P/N

6505014559983

NSN

6505-01-455-9983

View More Info

ROCEPHIN

CEFTRIAXONE SODIUM,USP

NSN, MFG P/N

6505014559983

NSN

6505-01-455-9983

MFG

ROCHE LABORATORIES INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CEFTRIAXONE EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTRIAXONE SODIUM STERILE USP POWDER FORM 1GM P-B BT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: PIGGYBACK

98-0482

IPECAC SYRUP,USP

NSN, MFG P/N

6505014562066

NSN

6505-01-456-2066

View More Info

98-0482

IPECAC SYRUP,USP

NSN, MFG P/N

6505014562066

NSN

6505-01-456-2066

MFG

DEFENSE MEDICAL STANDARDIZATION BOARD

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: IPECAC SYRUP USP 7% 30ML BT 12S
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 7%, 30 ML BOTTLES; 12 PER PACKAGE